Archive
View current news AllNewsInnovationInnovationTechnologyTechnologyOtherOther
08 Aug 2024
GrayMatters Health was granted approval for marketing its technology by the Ministry of Health in Israel
18 Mar 2024
The Advisory Board of Corundum Systems Biology, Professor Eran Segal of Weizmann Institute of Science, was invited to the Nobel Turing Challenge Initiative Workshop 2024 as a Keynote Speaker
28 Dec 2023
Corundum Systems Biology Invests in a Biotech Company Specializing in Improved Reproductive Health for Women
08 Dec 2023
GrayMatters Health was granted approval for marketing its technology by the Ministry of Health in Israel
15 Nov 2023
Joy Ventures Rebrands as Corundum Neuroscience, Launching New Venture Builder and Fund to Spur Neuroscience Technology Innovation
14 Sep 2023
Corundum Innovation Co., Ltd. elevates the Power of Convergence with new Boston Location Dedicated to Science and Technology
31 May 2023
Corundum Systems Biology Invests in a Biotech Firm Focused on Skin Health
25 Apr 2023
U.S. FDA Grants GrayMatters Health 510(k) Clearance to Market Prism for PTSD
21 Apr 2023
Corundum to Sponsor Harvard Chan Microbiome in Public Health Center Symposium
13 Dec 2022
Joy Ventures co-sponsored the symposium focused on Augmenting Brain Functions with MIT
22 Nov 2022
Corundum Systems Biology Participates in Concerto Biosciences Series A Financing Round raising $23 million
08 Sep 2022
Theranica, a Corundum’s portfolio, raised $45 million in its Series C financing round
17 Aug 2022
A Statement from Corundum System Biology Inc. in Advance of the International Human Microbiome Consortium Congress
19 Jan 2022
Initial Closing of Corundum’s Second Israeli VC Fund, and Start of Consulting Service for New Business Development
10 Jan 2022
Interview Article by Japan Patent Office and ASCII about IP Strategies of Israeli Startups